The SFP operates with minimal administrative costs allowing most of its received funds to go directly to supporting information and advocacy work, publications and workshops.
To ensure that the SFP continues to be independent and flexible, it receives a vast majority of its income from the SFP Partners: Cancer Research UK, the European Heart Network (EHN), the Dutch Cancer Society (DSC) and the Action on Smoking and Health (UK) (ASH (UK)). SFP also receives funding from the European Commission, Bloomberg Philanthropies and the Norwegian Cancer Society.
We are 100% transparent regarding our financial income; yearly income sources can be found in the final section of each of SFP's annual reports. Please consult the Annual Reports section for more information.
SFP Transparency and Funding
SFP is a strategic, independent and flexible partnership between Action on Smoking and Health (UK), Cancer Research UK and the European Heart Network. SFP represents the shared interest of our partners in promoting tobacco control policies and research at EU and Member State level, and we are registered on the EU’s Transparency Register under 6403725595-50.
The SFP Coalition is a new specialised network without legal personality, formed in 2014, composed of independent organisations working together to pursue common tobacco control advocacy goals and provide a framework for partner organisations to support each other for specific campaigns at EU or national level. SFP Coalition membership is free of charge.
SFP and the Smoke Free Partnership Coalition (SFPC) are non-profit making, and independent of industry, commercial and business or other conflicting interests. We are fully committed to transparency and independence in all aspects of our work. We are committed to open and transparent dialogue and ensuring accurate representation of our activities and policies.
SFP finances are fully transparent and publicly available in its Annual Reports which are published online on our website.
In 2015, SFP Main Partners contributions (Action on Smoking and Health UK, Cancer Research UK and European Heart Network) 23,40%
- SFP Associate Partner (Norwegian Cancer Society) 1,75%
- EU Operating Grant 53,81%
- The International Union Against Tuberculosis and Lung Disease, The Bloomberg Initiative to Reduce Tobacco Use Grant 19,08%
- Unrestricted educational grants (GSK, Pfizer) 1,75%
- Other income 0,16%
- Financial income 0,06%